The role of C5 is also being studied in C3 glomerulopathy, a rare disease of the kidney in which acquired autoantibodies target the C3 or C5 convertases, dysregulating complement activation (Smith et al., 2019). This evidence concerns the gene C3 and complement 3 glomerulopathy.